-
Mashup Score: 0
Focus on fibrosis, inspired by the Review on p633.
Source: www.nature.comCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 0#OctoberIs4Livers campaign aims to ‘turn the tide’ during Liver Cancer Awareness Month - 7 month(s) ago
Liver Cancer Awareness Month, celebrated every October, seeks to raise awareness about the third deadliest cancer in the United States, with approximately 41,000 new cases and as many as 30,000 deaths each year.To educate physicians on liver cancer management and prevention while empowering patients impacted by liver cancer, the Global Liver Institute has launched a social media campaign with the
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
#ICYMI from @GlobalLiver ❗ #OctoberIs4Livers campaign aims to ‘turn the tide’ during #LiverCancerAwarenessMonth 📅 https://t.co/ie0bU74pQz
-
-
Mashup Score: 0Gastroenterology - 7 month(s) ago
We present the latest EMJ Gastroenterology eJournals, including peer-reviewed articles, insightful interviews, and breaking news in this field.
Source: www.emjreviews.comCategories: Gastroenterology, Latest HeadlinesTweet-
An aerial view of the Bella Center in Copenhagen🌿🌞 lots of interesting sessions happening this week on #IBD #gastroenterology #guthealth #UEG Check out our articles in this specialty: https://t.co/cPi0G3Qs1B https://t.co/g4zWFzPkYg
-
-
Mashup Score: 1
Clinical Transplantation is an international transplantation journal publishing the latest research surrounding organ and tissue transplant surgery.
Source: onlinelibrary.wiley.comCategories: Gastroenterology, Latest HeadlinesTweet-
Includes great graphics detailing immunosuppression complications, post liver transplant metabolic health management, vaccine management and malignancy screening 👇 https://t.co/WgW9vAh2ql #livertwitter https://t.co/DywKpGvylT
-
Fantastic article by @moden87 @hannahfayroth @AnjanaPillaiMD et al in @CliniTransplant 👏 🌟Evolving challenges with long-term care of liver #transplant https://t.co/WgW9vAh2ql #livertwitter #livertransplant #transplantation https://t.co/0I1fpuBBwK
-
-
Mashup Score: 0
The FDA has approved Pfizer’s 2 mg once-daily Velsipity, an oral, selective sphingosine-1-phosphate receptor modulator, to treat adult patients with moderately to severely active ulcerative colitis, according to a company press release. This approval designates Velsipity (etrasimod) as only the second S1P receptor modulator available for the treatment of UC since Zeposia (Ozanimod, Bristol
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
#ICYMI from @US_FDA, @pfizer: #FDA approves #Pfizer’s #Velsipity 💊 as ‘oral, once-daily pill’ for #ulcerativecolitis https://t.co/YWtJom5soo
-
-
Mashup Score: 3
een IMH and HCC tumorigenesis. Approach and Results: A case-control study was designed to investigate microbial landscape and characteristic microbial signatures of HBV-related HCC tissues adopting metagenomics next-generation sequencing. Microbiome-based molecular subtyping of HCC tissues was established by nonmetric multidimensional scaling. The tumor immune microenvironment of 2 molecular subtypes was characterized by EPIC and CIBERSORT based on RNA-seq and verified by immunohistochemistry. The gene set variation analysis was adopted to explore the crosstalk between the immune and metabolism microenvironment. A prognosis-related gene risk signature between 2 subtypes was constructed by the weighted gene coexpression network analysis and the Cox regression analysis and then verified by the Kaplan-Meier survival curve. IMH demonstrated in HBV-related HCC tissues was comparably lower than that in chronic hepatitis tissues. Two microbiome-based HCC molecular subtypes, defined as bacteri
Source: journals.lww.comCategories: Gastroenterology, Latest HeadlinesTweet-
Li S et al. La heterogeneidad microbiana intratumoral afecta el microambiente inmunológico del tumor y determina el resultado clínico del CHC relacionado con el VHB #LiverTwitter https://t.co/nWh2TXnrJb https://t.co/AhMeq6Sov7
-
-
Mashup Score: 0
Gastrointestinal disease often presents differently in pediatric patients, and providers must be aware of even subtle symptoms, such as changes in stool pattern or lags in growth and development, Dedrick Moulton, MD, told Healio. Although an occasional stomachache or diarrhea is common among children, frequent or more severe symptoms may be indicative of an underlying GI disorder. According to
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
Q&A with @DedrickMaxx of @LSU: Providers must listen, recognize #GI ‘alarm signals’ in #pediatricpatients https://t.co/toaWntr0EK
-
-
Mashup Score: 0
een IMH and HCC tumorigenesis. Approach and Results: A case-control study was designed to investigate microbial landscape and characteristic microbial signatures of HBV-related HCC tissues adopting metagenomics next-generation sequencing. Microbiome-based molecular subtyping of HCC tissues was established by nonmetric multidimensional scaling. The tumor immune microenvironment of 2 molecular subtypes was characterized by EPIC and CIBERSORT based on RNA-seq and verified by immunohistochemistry. The gene set variation analysis was adopted to explore the crosstalk between the immune and metabolism microenvironment. A prognosis-related gene risk signature between 2 subtypes was constructed by the weighted gene coexpression network analysis and the Cox regression analysis and then verified by the Kaplan-Meier survival curve. IMH demonstrated in HBV-related HCC tissues was comparably lower than that in chronic hepatitis tissues. Two microbiome-based HCC molecular subtypes, defined as bacteri
Source: journals.lww.comCategories: Gastroenterology, Latest HeadlinesTweet-
Li S et al. Intratumoral microbial heterogeneity affected tumor immune microenvironment and determined clinical outcome of HBV-related HCC #LiverTwitter https://t.co/nWh2TXnrJb https://t.co/AZVodAkAqB
-
-
Mashup Score: 1UEG 2021 Interview - Helena Cortez-Pinto - 7 month(s) ago
I considered, at the time, and still consider, that gastroenterology is a very interesting and diverse specialty. In fact…
Source: www.emjreviews.comCategories: Gastroenterology, Latest HeadlinesTweet-
#UEG President @hlcortezpinto welcomed the #gastroenterology community in the Opening Plenary session at #UEGWeek2023 Read her interview with EMJ here: https://t.co/BVfRdpHXAy https://t.co/lwVBaLuhAL
-
-
Mashup Score: 0Drug rediscovery in gastroenterology: from off-label to on-label use of thioguanine in inflammatory bowel disease - 7 month(s) ago
Drug rediscovery refers to the principle of using ‘old’ drugs outside the indications mentioned in the summary of product characteristics. In the past decades, several drugs were rediscovered in a wide variety of medical fields. One of the most recent examples is the unconditional registration of thioguanine (TG), a thiopurine derivative, in patients with inflammatory bowel disease in the Netherlands. In this paper, we aim to visualise potential hurdles that hamper drug rediscovery in general, emphasise the global need for optimal use and development of potentially useful drugs, and provide an overview of the registration process for TG in the Netherlands. With this summary, we aim to guide drug rediscovery trajectories in the near future.
Source: gut.bmj.comCategories: Gastroenterology, Latest HeadlinesTweet-
#GUTImage from the #RecentAdvancesInClinicalPractice paper by de Boer et al on the paper "Drug rediscovery in gastroenterology: from off-label to on-label use of thioguanine in inflammatory bowel disease" via https://t.co/gW37PSPmvB @amsterdamumc #IBD https://t.co/HzndEzixys
-
Need some reading in your #UEGweek lunchbreak? Then check out our Focus issue on liver fibrosis, selected content is FREE to access for a limited time https://t.co/zB6A4dQEOx https://t.co/TgPJdeuhZP